Shares of HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) have been assigned a consensus rating of “Buy” from the twelve research firms that are currently covering the firm, Marketbeat.com reports. Twelve investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued a report on the stock in the last year is $101.67.
Several research analysts have commented on the company. Robert W. Baird boosted their target price on HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 4th. KeyCorp boosted their price target on shares of HealthEquity from $95.00 to $100.00 and gave the company an “overweight” rating in a research note on Wednesday, June 5th. Barrington Research restated an “outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Friday. JMP Securities boosted their price objective on HealthEquity from $101.00 to $105.00 and gave the company a “market outperform” rating in a research note on Tuesday, June 4th. Finally, Bank of America reaffirmed a “buy” rating and set a $105.00 price target on shares of HealthEquity in a research note on Wednesday, July 3rd.
Get Our Latest Research Report on HQY
Insider Activity
Hedge Funds Weigh In On HealthEquity
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Motley Fool Asset Management LLC boosted its position in HealthEquity by 3,001.0% in the first quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock valued at $307,097,000 after buying an additional 3,640,748 shares during the last quarter. Norges Bank acquired a new stake in shares of HealthEquity during the fourth quarter worth about $43,482,000. Vaughan Nelson Investment Management L.P. acquired a new stake in shares of HealthEquity in the 1st quarter valued at $49,443,000. Wasatch Advisors LP boosted its stake in HealthEquity by 8.3% in the first quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock valued at $604,803,000 after acquiring an additional 569,249 shares in the last quarter. Finally, Mackenzie Financial Corp lifted its holdings in shares of HealthEquity by 16.0% in the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after buying an additional 325,906 shares during the period. 99.55% of the stock is currently owned by institutional investors.
HealthEquity Stock Performance
NASDAQ HQY opened at $79.56 on Monday. The company has a current ratio of 4.39, a quick ratio of 4.39 and a debt-to-equity ratio of 0.44. HealthEquity has a 1 year low of $61.81 and a 1 year high of $88.26. The firm’s fifty day moving average price is $77.47 and its two-hundred day moving average price is $79.72. The firm has a market capitalization of $6.92 billion, a P/E ratio of 86.48, a price-to-earnings-growth ratio of 1.34 and a beta of 0.57.
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its quarterly earnings data on Monday, June 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.08. The firm had revenue of $287.60 million during the quarter, compared to the consensus estimate of $278.78 million. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%. As a group, research analysts anticipate that HealthEquity will post 2.12 EPS for the current year.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Further Reading
- Five stocks we like better than HealthEquity
- Learn Technical Analysis Skills to Master the Stock Market
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
- Roth IRA Calculator: Calculate Your Potential Returns
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MarketBeat Week in Review – 8/26 – 8/30
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.